If Genmab's drug tisotumab vedotin is approved in the US in October as expected, the firm will take on its own sales and marketing for the first time.
The Danish biotech company is currently expanding its workforce to prepare for participating in commercial activities with US company Seagen, formerly Seattle Genetics, with which it shares the rights for tisotumab vedotin equally.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP recommends nine new drugs, rejects one
Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.
WS Audiology still chewing over listing of online hearing company
The hearing giant is still mulling over the independent listing of Hear.com.
CEO at WSA: No clarity on EQT exit plans yet
The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.
Oticon: Covid-19 led to debates about product launches
The unpredictable world situation in the spring of 2020 meant that the timing of product launches was frequently discussed at Demant-owned Oticon, located in Denmark.
EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry
With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.
Associate Director, PV QA - Y-mAbs Therapeutics 
Medical Director (diabetes and obesity) - Zealand Pharma 
CMC Senior Project Manager - Genmab 
Analytical Specialist – Product Lifecycle Management (PLM), Orifarm 
Bioinformatician / Immunoinformatician - Vaccibody 
KLIFO is looking for an experienced and skilled Proposal Manager for one of our offices in Denmark, Sweden or Germany 
Employee of the regulatory department with knowledge of food safety and legislation within dietary supplements and medicines 
Principal Scientist, In Vivo Pharmacology 
Senior Clinical Research Specialist - Ambu 
A tech-savvy Project Manager Oncology (m/f/x) with a passion for communication and cross-functional collaboration - Daiichi-Sankyo 
Project Manager, Adcendo ApS 
Director of Communications – Evaxion Biotech 
Medical Scientific Liaison Dermo aesthetic, IBSA 
Global Senior Medical Advisor – Neurology Pipeline Projects, Lundbeck